Lv3
280 积分 2024-07-11 加入
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
10小时前
已完结
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
1个月前
已完结
The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets
1个月前
已完结
Mechanisms of PTEN loss in cancer: It’s all about diversity
1个月前
已完结
Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma
1个月前
已完结
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories
1个月前
已完结
FISH analysis of MALT lymphoma‐specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma
2个月前
已完结
Nondestructive Quality Control of HER2 Control Cell Line Sections
2个月前
已完结
Estrogen, progesterone, and HER‐2 receptor immunostaining in cytology: The effect of varied fixation on human breast cancer cells
2个月前
已完结
HER2 staining of breast cancer is reduced under the current protocol of Ventana PATHWAY anti‐HER‐2/neu (4B5)
2个月前
已完结
皖公网安备34019202002308
